市場調查報告書
商品編碼
1358973
2030 年醫療保健市場人工智慧 (AI) 預測:按產品、技術、用途、最終用戶和地區進行的全球分析Artificial Intelligence in Healthcare Market Forecasts to 2030 - Global Analysis By Offering, Technology, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球人工智慧(AI)醫療保健市場規模將達到224.2億美元,預測期內年複合成長率為45.6%,預計到2030年將達到3,110.4億美元。
人工智慧 (AI) 涉及使用演算法和軟體來分析複雜的醫療資料。人工智慧被定義為將基於人類智慧的各種功能,如推理、學習和解決問題的能力,應用於生物學、電腦科學、數學、語言學、心理學和工程學等各個領域的智慧系統。人工智慧在領域的應用正在提高醫學研發的效率、創造力和成本效益。
根據 2020 年 NCBI 的一項研究,基於人工智慧的演算法在由醫療專業人員診斷為陰性的 25 名患者資料正確識別了 68% 的 COVID-19 陽性病例。
隨著製藥和醫療技術公司增加人工智慧(AI)支出以發展業務,該行業預計將迅速擴張。普華永道表示,人工智慧 (AI) 有效、快速,並且以顯著更低的成本執行營運任務。此外,人工智慧將協助醫療保健專業人員早期發現和診斷所有疾病。因此,該行業的大多數醫療保健提供者都在增加投資。
儘管人工智慧(AI)在醫療保健行業的應用較多,但其普及仍然較低。因為醫療保健提供者必須處理幾個複雜的問題。人工智慧的整合可能會引入錯誤,並造成患者的診斷和所提供的藥物之間的脫節。資料隱私問題也是領域領域人工智慧的一個障礙。許多國家都有專門的法律來保護病患的健康資訊。然而,違反這項法規可能會產生財務和法律後果。由於不道德地收集敏感資料等問題,病患資料安全風險也隨之增加。因此,對病患安全和不道德資料收集的擔憂日益增加,阻礙了整體市場的擴張。
大型複雜資料,也稱為巨量資料,包括點擊流、網路和社交媒體互動、心電圖 (ECG)、X光和脈搏血氧計等醫療設備的讀數、醫療申請等申請記錄,用於醫療保健領域來識別從電子健康記錄(EMR)、藥物、生物辨識資料等收集的資訊。在過去的年度中,隨著醫療保健專業人員採用電子健康記錄(EHR)、數位化檢查幻燈片和高解析度放射影像,巨量資料收集和分析工具的發展變得更加複雜和廣泛。 。
人工智慧是一個複雜的系統,企業需要具有一定技能的人員來設計、管理和部署人工智慧系統。例如,使用人工智慧系統的個人應該熟悉深度學習、認知運算、機器學習和機器智慧等技術。然而,複製人腦行為並將人工智慧解決方案整合到現有系統中是一項艱鉅的任務,需要大量的資料處理。即使很小的錯誤也會導致系統故障或對預期結果產生負面影響。
在分析期間,COVID-19的影響預計將顯著推動醫療保健市場的人工智慧(AI)。 AI 透過監測病毒傳播來診斷 COVID-19 的能力顯著增加了對基於 AI 的工具和解決方案的需求。此外,對用於分析人群流行病風險評估和捕獲即時資料的電子健康記錄(EHR)系統的需求不斷成長,也促進了市場的擴張。
在預測期內,軟體領域佔據了最大的市場佔有率,這主要是由於人工智慧驅動的軟體解決方案在醫療機構、醫療保健提供者、消費者和付款人之間的快速普及。軟體領域的擴張是由醫療保健產業對基於人工智慧的軟體解決方案的使用增加投資所推動的。此外,這種成長與人工智慧和基於機器學習的技術在世界各地各種醫療保健應用中的越來越多的使用有關。
預計製藥和生物技術公司部門在預測期內將呈現良好的成長。在醫療保健領域,人工智慧(AI)被用來支援基因序列測定工作以及預測藥物的有效性和安全性。該市場領域的擴張是由不同市場參與企業之間不斷增加的合作夥伴關係所推動的。例如,默克公司和內華達州楊森製藥公司於2020年7月共同開發了人工智慧診斷工具。該技術有助於提高對被忽視的熱帶疾病 (NTD)、血吸蟲病和土源性蠕蟲病 (STH) 的檢測。
由於 IT 基礎設施的快速發展和專門從事人工智慧技術的創業項目,亞太地區預計將在整個外推期內佔據最大佔有率。採用率的推動因素是私人投資者、創業投資和非營利組織為改善治療結果、資料分析、安全性和降低成本而增加的投資。此外,推動亞太市場成長的主要原因之一是支持和促進醫療機構和醫療服務提供者快速採用基於人工智慧的技術的有利政府政策。
由於對尖端數位技術的需求不斷成長,預計北美在預測期內將實現盈利成長。北美擁有強大且發達的醫療保健、IT 和通訊基礎設施,因此醫療保健領域的人工智慧 (AI) 市場正在不斷擴大。該地區的醫療保健產業也得到鼓勵使用尖端數位技術的政府法規的支持。北美擁有龐大的患者群。據估計,超過一半的美國患有一種或多種慢性病。因此,該地區的住院患者人數不斷增加。
According to Stratistics MRC, the Global Artificial Intelligence in Healthcare Market is accounted for $20.87 billion in 2023 and is expected to reach $175.00 billion by 2030 growing at a CAGR of 35.5% during the forecast period. Artificial intelligence (AI) is defined as the study of intelligent agents, i.e., any agent or tool that has the ability to comprehend and grasp its environment and, as a result, to determine the appropriate course of action to increase its chances of succeeding. AI also refers to situations in which machines can mimic the learning and problem-solving processes of the human brain.
According to the statistics published by the CI security, data breaches in the healthcare industry increased by around 36.0% in the second half of 2020. This revealed that around 21.3 million patient records were hampered.
Electronic health records, medical equipment, wearable sensors, and genomics are just a few of the sources of the data explosion in the healthcare sector. This flood of data contains a wealth of insights that AI is just beginning to unlock. Moreover, AI algorithms can make predictions, find hidden patterns in this data, and assist healthcare professionals in making decisions that are supported by the best available evidence.
Data security and privacy are of utmost importance in the healthcare industry because of the sensitive patient data that is handled there. Additionally, an increased risk of data breaches, which could potentially harm patients and have legal repercussions, exists as AI systems become more dependent on access to large volumes of patient data. It's difficult to balance providing AI with access to data while maintaining strict data security protocols.
AI facilitates the growth of telemedicine and remote patient monitoring, which have become more popular, particularly during the COVID-19 pandemic. Furthermore, AI-powered virtual healthcare platforms make it possible to manage chronic diseases, monitor symptoms, and conduct remote consultations, ensuring continuity and accessibility of care, especially for people living in rural or remote areas.
Healthcare organizations are attractive targets for cyber attacks as they gather enormous amounts of private patient data. Patient confidentiality may be violated, patient records may be compromised, and identity theft may occur as a result of data breaches and security breaches. However, to lessen these risks, it is essential to maintain strong data security procedures, encryption, and regulatory compliance.
The COVID-19 pandemic has significantly altered healthcare priorities and accelerated the adoption of technology, including artificial intelligence. Increased investments in AI-driven solutions for telemedicine, vaccine development, drug discovery, and pandemic response followed the pandemic's emphasis on the value of effective healthcare delivery, remote monitoring, and quick diagnostics. Moreover, COVID-19 highlighted the potential of AI to improve healthcare resilience, data-driven decision-making, and the development of creative solutions for upcoming healthcare challenges, even though it puts a strain on healthcare resources and supply chains.
During the forecast period, it is anticipated that the services segment will hold the largest share. For the successful integration and operation of healthcare IT systems, such as electronic health records (EHRs), telemedicine platforms, and artificial intelligence applications, a wide range of services, including consulting, implementation, maintenance, and support services, are required. Additionally, services are essential for assisting healthcare providers to make the most of their technology investments, ensure regulatory compliance, and deliver high-quality patient care in an environment where healthcare is becoming more and more digitized.
The artificial intelligence market in healthcare is seeing the highest CAGR in the precision medicine segment. Customizing medical care and interventions for each patient based on genetic make-up, way of life and unique health characteristics is known as precision medicine. The development of personalized treatment plans, advances in genomics, and the growing accessibility of patient-specific data have all contributed to the growing popularity of this strategy. Moreover, precision medicine is a focus for research, investment, and innovation in the healthcare sector because it holds the promise of more effective therapies, diminished side effects, and improved patient outcomes.
The artificial intelligence market in healthcare is anticipated to hold the largest share in the North American region, particularly the United States. Large patient populations, a thriving pharmaceutical industry, significant investments in medical research and technology, and a well-developed healthcare infrastructure are just a few examples of the factors that contribute to this dominance. Additionally, the area has also led the way in implementing healthcare IT solutions, such as telemedicine and electronic health records (EHRs), which has helped it gain market share. The continued advancements and investments in healthcare technology and services will probably maintain this region's prominence.
In the global healthcare market, the Asia-Pacific region is anticipated to hold the highest CAGR. This rapid growth is caused by a number of variables, including rising healthcare costs, an aging population, an increase in the prevalence of chronic diseases, and increased access to healthcare services. Furthermore, the Asia-Pacific region is also heavily investing in healthcare infrastructure, medical technologies, and digital health solutions, making it a hub for market growth and healthcare innovation.
Some of the key players in Artificial Intelligence in Healthcare market include: Micron Technology Inc., Allscripts Healthcare Solutions, Inc., Medtronic, Enlitic Inc., Google Inc., General Vision, Inc., General Electric Company, Intel Corporation, Amazon Web Services Inc., Nuance Communications Inc., DeepMind Technologies Limited, Next IT Corporation, Koninklijke Philips N.V, Johnson & Johnson Services, Inc, Cloudmedx Inc., IBM Corporation, NVIDIA Corporation, Microsoft Corporation, Hewlett Packard Enterprise Company, Siemens Healthcare and Welltok, Inc.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor, is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
In February 2023, General Electric has signed an agreement with Iraq to set up new power plants and expand capacity at existing units in the country. The deal, which was signed between the US conglomerate and Iraq's Ministry of Electricity, also aims to maintain installed power generation and transmission infrastructure, establish new substations to relieve grid congestion and boost the connectivity between the Jordanian and Iraqi power grids, GE said on Thursday.
In January 2023, Amazon Web Services, Inc. announced its Strategic Collaboration Agreement (SCA) with Slalom, LLC to develop vertical solutions and accelerators on AWS for their customers in healthcare, life sciences, financial services, energy, and media and entertainment industries.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.